Greg Sargen, MBA
With over 30 years of financial experience, Mr. Greg Sargen most recently served as Chief Financial Officer and Executive Vice President of Corporate Development and Strategy at Cambrex Corporation. Prior to Cambrex, he served as Executive Vice President and Chief Financial Officer at Expanets, Vice President of Finance in the Chemicals Manufacturing Division of Fisher Scientific, and held executive positions with Merck, Heat and Control, and Deloitte & Touche. In addition to his role at Umoja, he also serves on the boards of Protara Therapeutics, Avid Bioservices, and Kindeva Drug Delivery. Mr. Sargen is a Certified Public Accountant (non-practicing) and holds an MBA in Finance from The Wharton School of the University of Pennsylvania as well as a B.S. in Accounting from Pennsylvania State University.